. TRPV4 is specifically expressed in endothelial cells, but not in monocytes/macrophages. Human THP-1 monocytic cells were incubated with vehicle (0.1% DMSO) or 100 nM PMA for 48 h to induce differentiation into macrophages, then total RNA was isolated for RT-PCR, GAPDH was used as the loading control, RNA isolated from HUVECs was used as the positive control.
. GSK1016790A promotes the phosphorylation of eNOS at S1177, while decreases the phosphorylation of eNOS at T495. A, HUVECs were treated with 10 nM GSK1016790A (GSK101) for indicated times, then phosphorylation of eNOS at T495 and S1177 were analyzed by Western blotting. Total eNOS from the same stripped membrane was used as loading control. B, Densitometric analysis of A. Data were expressed as means ± SEM, ***p<0.001 vs control (0 min). Figure S3 . Laminar flow does not affect TRPV4 mRNA or protein expression A, HUVECs were subjected to laminar flow for indicated time, then RNA was isolated for real time PCR analysis to examine TRPV4 gene expression. Laminar flow induced flowresponsive KLF2 gene upregulation from 3 h to 24 h, without affecting TRPV4 gene expression, **p<0.01 vs control. N.S. denotes non-significant difference. B, HUVECs were treated as described in A, and whole cell lysates were collected for western blot analysis to detect TRPV4 protein expression. Figure S4 . TRPV4 depletion inhibits flow induced eNOS phosphorylation but does not affect eNOS and KLF2 expression. A-B, Silencing efficiency of TRPV4 siRNA. Knockdown of human TRPV4 was performed using TRPV4 siRNA (siTRPV4). A non-targeting siRNA Control (siNC) was used as a control. HUVECs were transfected with siNC (25 nM) or siTRPV4 siRNA (25 nM) with Lipofectamine 2000 (Invitrogen) for 4 h according to the manufacturer's instructions. Cells were cultured for an additional 48 h in complete media at 37°C, and mRNA and proteins were extracted for real time PCR (Panel A, ***p<0.001 vs. siNC) and Western blot (Panel B) analysis, respectively. C, TRPV4 siRNA does not affect KLF2 and eNOS gene expression. D, TRPV4 siRNA inhibits flow induced eNOS phosphorylation (Ser1177). HUVECs were treated as described in A, then subject to laminar flow for 15 min. Whole cell lysates were collected and subjected to Western blot using antibodies as indicated. 
